The Indian Council of Medical Research (ICMR) on Sunday said that it has conducted a total of 1,95,748 tests for coronavirus as on April 12.
"A total of 1,95,748 samples from 1,81,028 individuals have been tested as on April 12, 2020, 9 PM," ICMR said in a statement.
Earlier today, the apex health research body said that no vaccine has yet been developed for the treatment of coronavirus.
However, over 40 vaccines are under various stages of development but none have reached the final stage.Speaking to media Dr Manoj Murhekar of ICMR said, "More than 40 vaccines are under development but none have reached the next stage. As of now, there is no vaccine."
"In the last five days, the average number of samples that have been tested is 15,747 per day and the average number of samples which tested positive is 584," he added.
With 918 new positive COVID-19 cases in the last 24 hours and 31 deaths, the total number of coronavirus cases in India on Sunday climbed to 8447, including 764 cured and discharged, 1 migrated and 273 deaths, said the Ministry of Health and Family Welfare.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
